Speece Thorson Capital Group Inc. Sells 229,891 Shares of Henry Schein, Inc. (NASDAQ:HSIC)

Speece Thorson Capital Group Inc. lessened its position in Henry Schein, Inc. (NASDAQ:HSIC - Free Report) by 97.0% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 7,024 shares of the company's stock after selling 229,891 shares during the quarter. Speece Thorson Capital Group Inc.'s holdings in Henry Schein were worth $481,000 at the end of the most recent quarter.

Other institutional investors have also recently bought and sold shares of the company. Investment Management Corp VA ADV bought a new position in Henry Schein in the 4th quarter worth $32,000. Rakuten Securities Inc. acquired a new stake in Henry Schein in the 1st quarter worth $34,000. UMB Bank n.a. grew its position in Henry Schein by 23.2% in the 1st quarter. UMB Bank n.a. now owns 1,066 shares of the company's stock worth $73,000 after purchasing an additional 201 shares during the last quarter. Allworth Financial LP grew its position in Henry Schein by 24.5% in the 1st quarter. Allworth Financial LP now owns 1,178 shares of the company's stock worth $78,000 after purchasing an additional 232 shares during the last quarter. Finally, Menard Financial Group LLC acquired a new stake in Henry Schein in the 4th quarter worth $92,000. Institutional investors own 96.62% of the company's stock.

Wall Street Analyst Weigh In

Several analysts have issued reports on the stock. Wall Street Zen lowered shares of Henry Schein from a "buy" rating to a "hold" rating in a research report on Thursday, April 17th. Wells Fargo & Company decreased their price target on shares of Henry Schein from $80.00 to $75.00 and set an "equal weight" rating on the stock in a research report on Tuesday, May 6th. Evercore ISI raised their price target on shares of Henry Schein from $72.00 to $78.00 and gave the stock an "in-line" rating in a research report on Wednesday. Piper Sandler decreased their price target on shares of Henry Schein from $83.00 to $77.00 and set an "overweight" rating on the stock in a research report on Wednesday, April 30th. Finally, Barrington Research decreased their price target on shares of Henry Schein from $90.00 to $86.00 and set an "outperform" rating on the stock in a research report on Tuesday, May 6th. Six equities research analysts have rated the stock with a hold rating, five have assigned a buy rating and one has given a strong buy rating to the company's stock. According to MarketBeat, the company has an average rating of "Moderate Buy" and a consensus price target of $79.70.

Henry Schein Price Performance

Shares of Henry Schein stock opened at $73.42 on Friday. The company has a debt-to-equity ratio of 0.50, a quick ratio of 0.75 and a current ratio of 1.38. The firm's 50-day simple moving average is $71.56 and its 200-day simple moving average is $71.33. Henry Schein, Inc. has a twelve month low of $60.56 and a twelve month high of $82.49. The firm has a market cap of $8.94 billion, a P/E ratio of 22.94, a price-to-earnings-growth ratio of 2.37 and a beta of 0.87.

Henry Schein (NASDAQ:HSIC - Get Free Report) last issued its earnings results on Monday, May 5th. The company reported $1.15 earnings per share for the quarter, beating the consensus estimate of $1.11 by $0.04. Henry Schein had a net margin of 3.21% and a return on equity of 14.87%. The business had revenue of $3.17 billion for the quarter, compared to analyst estimates of $3.24 billion. During the same period in the previous year, the business earned $1.10 EPS. The firm's revenue was down .1% on a year-over-year basis. As a group, research analysts expect that Henry Schein, Inc. will post 4.74 EPS for the current fiscal year.

Henry Schein Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.

Want to see what other hedge funds are holding HSIC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Henry Schein, Inc. (NASDAQ:HSIC - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.